Pharmaceutical Executive October 24, 2025
Chris O’Dell, SVP of market solutions at Turquoise Health, discusses why it’s important to a shine a light on this aspect of the healthcare ecosystem.
Pharmaceutical Executive: What impact will DTC programs have on prescription drug prices?
Chris O’Dell: I’m optimistic that they will have an impact in the long term. In the near term, however, what was announced has limited impact. At the end of the day, complexity is the enemy here.
The fact that no one knows what a drug is going to cost them before they get it is clearly a problem in the US. Shining a lot on that complexity and showing that list prices on drugs are way too high is something that everyone...







